-
AI, Machine Learning & Computational Biology3 days agoMikhail, Davis embody the FDA’s stabilization, Seehafer signals AI revolution is coming
Newly solidified in their roles as the heads of CBER and CDER, Karim Mikahil and Michael Davis have been working for months to right the ship...
-
Global Biotechnology & Pharmaceutical Markets4 days agoWebinar: The Massive Scale of GLP-1s: Evolving Health, Healthcare and Markets
Watch this discussion on how GLP-1 drugs for obesity are changing the shape of U.S. healthcare. From direct-to-consumer portals to pharmacy deals, how these drugs reach...
-
Clinical Trials & Development4 days agoNovo’s canned heart disease trials, Novartis’ clinical fails, first approval for Alexander disease
September has been a rough month already for Novo Nordisk, which canned two more late-stage trials of its embattled IL-6 inhibitor, and Novartis, which took Phase...
-
Regulatory Intelligence & Drug Approvals2 weeks agoNovartis’ and BMS’ paused CAR T trials, RevMed’s pancreatic cancer approval, more MFN deals
Novartis hits pause on several CAR T trials after three patient deaths, followed by Bristol Myers Squibb after separate safety signals; Revolution Medicines scores early FDA...
Drug Discovery & Therapeutics15 hours ago
Carbon Dots Emerge as a Powerful Weapon Against Superbugs and Biofilms
Clinical Trials & Development15 hours ago
Your Zip Code May Shape Your Breast Cancer Tumor’s Genetics and Your Survival Odds
Drug Discovery & Therapeutics15 hours ago
Azithromycin Resistance in Gonorrhea Shifts Genetic Ground, Challenging Molecular Surveillance
Fierce Biotech6 months ago
Scientists turn pig semen extract into eye drops that kill cancer in mice
Endpoints News6 months ago
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
Uncategorized6 months ago
